Therapies in Development for the Treatment of Pancreatic Cancer
Margaret A. Tempero, MD, discusses therapies that are currently in development for the treatment of pancreatic cancer.
Margaret A. Tempero, MD, director, Pancreas Center, University of California, San Francisco, discusses therapies that are currently in development for the treatment of pancreatic cancer.
Clinical Pearls
- Pathways that are downstream of activated RAS, such as the MAPK and PI3K pathways, are potential targets for the treatment of pancreatic cancer
- Stromal depleting agents are also in development
- There is a lot of interest in optimizing vaccine strategies and changing the immune cell population in the microenvironment from a pro-tumor environment to an anti-tumor environment
Recent Videos
Related Content
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Article
Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More
